Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Simpson

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Cancer|July 10, 2001
No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasiaB A Carter, D L Page, P Schuyler, et al.
Cancer Research|November 4, 2000
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cellsH Kurokawa, A E Lenferink, J F Simpson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cellsJ W Greiner, F Guadagni, D Goldstein, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1995
Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosisM J Gaffey, S E Mills, H F Frierson, et al.
International Journal of Cancer|April 15, 1989
A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epitheliumR Muraro, M Nuti, P G Natali, et al.
Journal of the National Cancer Institute|December 22, 1999
Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasiaH Gobbi, W D Dupont, J F Simpson, et al.
Cancer Research|August 15, 1988
Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigenR Muraro, M Kuroki, D Wunderlich, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 1993
Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significanceM J Gaffey, H F Frierson, S E Mills, et al.
Journal of the National Cancer Institute|April 5, 1989
Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cellsF Guadagni, J Schlom, W W Johnston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189J F Simpson, R Gray, L G Dressler, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Cancer|July 10, 2001
No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasiaB A Carter, D L Page, P Schuyler, et al.
Cancer Research|November 4, 2000
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cellsH Kurokawa, A E Lenferink, J F Simpson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cellsJ W Greiner, F Guadagni, D Goldstein, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1995
Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosisM J Gaffey, S E Mills, H F Frierson, et al.
International Journal of Cancer|April 15, 1989
A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epitheliumR Muraro, M Nuti, P G Natali, et al.
Journal of the National Cancer Institute|December 22, 1999
Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasiaH Gobbi, W D Dupont, J F Simpson, et al.
Cancer Research|August 15, 1988
Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigenR Muraro, M Kuroki, D Wunderlich, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 1993
Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significanceM J Gaffey, H F Frierson, S E Mills, et al.
Journal of the National Cancer Institute|April 5, 1989
Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cellsF Guadagni, J Schlom, W W Johnston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189J F Simpson, R Gray, L G Dressler, et al.
Pageof 11